eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Head & Neck Surgery

Postcricoid Area, Malignant Tumors: Treatment

Author: Douglas B Villaret, MD, Residency Director, Assistant Professor, Department of Otolaryngology, Shands Hospital, University of Florida
Coauthor(s): Neal D Futran, MD, Director of Head and Neck Surgery, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Washington School of Medicine; Scott P Stringer, MD, MS, FACS, Professor and Chairman, Department of Otolaryngology and Communicative Sciences, University of Mississippi Medical Center; Associate Vice Chancellor for Clinical Affairs; Robert J Amdur, MD, Associate Chairman of Clinical Affairs, Associate Professor, Department of Radiation Oncology, Shands Hospital, University of Florida; William M Mendenhall, MD, Professor, Department of Radiation Oncology, Shands Hospital, University of Florida
Contributor Information and Disclosures

Updated: Jun 28, 2006

Treatment

Medical Therapy

Treatment for postcricoid cancer has undergone a transformation similar to that of the laryngopharyngeal area as a whole. Lately, researchers have sought ways to avoid the perceived morbidity of total laryngectomy. Many centers are relinquishing the primary surgery�postoperative radiation approach for an organ-preservation protocol. The scientific rationale for this model received support from a large US Department of Veterans Affairs laryngeal-preservation trial. This was a randomized study of more than 330 patients who received cisplatin and 5-fluorouracil chemotherapy delivered in a neoadjuvant setting. Patients with at least a partial response (>50%) also received radiation treatment. Nonresponders underwent total laryngectomy and postoperative radiation therapy. Overall survival rates for both methods were similar, and two thirds of survivors retained their larynx.

The European Organization for Research and Treatment of Cancer performed a similar trial for the hypopharynx, with stricter chemotherapy-response criteria. Only complete responders proceeded directly to radiation, while incomplete responders received total laryngectomy and partial or total pharyngectomy. Again, no significant survival difference was noted, and 42% of survivors retained their larynx.

To evaluate the effect of chemotherapy, a French group randomized a group of patients who had pyriform sinus cancer. The 2 arms of the study were neoadjuvant chemotherapy followed by radiation (regardless of tumor response) and standard surgery followed by postoperative radiation. Results showed that survival rates in the chemotherapy arm were almost half those of the surgical arm, suggesting that chemotherapy did not treat cancer, but that it acted mostly as a selection tool for cancers that would respond well to radiation.

The University of Florida treats T1 and favorable T2 tumors 6cc or less with hyperfractionated radiation to a total tumor dose of 74 Gy. T3-T4 and/or N2-N3 tumors often receive concomitant chemotherapy (if patient health status allows) or primary surgical management followed by postoperative radiation therapy. IMRT using the concomitant boost technique may be advantageous to irradiate postcricoid carcinomas in patients with a low-lying larynx and a short neck.

Surgical Therapy

Surgical excision followed by postoperative radiation is the treatment of choice for cancers not amenable to a conservation protocol (ie, tumors destroying cartilage, tumors too bulky for control with primary radiation). Some patients, if their functional disability is significant, choose this route even with smaller tumors, and a total laryngectomy offers improved swallowing and, rarely, improved vocalization. The minimum operation recommended is a total laryngectomy and partial pharyngectomy with a central (level 6) node dissection.

The hypopharynx is special in that studies show extensive submucosal spread of tumor and even skip lesions in this region. For these reasons, the surgeon must be more aggressive and obtain wider margins than in other areas of the head and neck. If the tumor is staged as a T2 or higher, perform a neck dissection (usually bilaterally because the postcricoid area is a midline structure that can send metastases to either side of the neck). The extent of neck dissection is debated widely and depends on various factors, including primary tumor extent and nodal metastases. Most commonly, perform a bilateral lateral neck dissection (level 2-4) with the inclusion of level 6. Often, a primary tracheoesophageal puncture is placed to allow early feeding via a Levine tube and eventual voice restoration.

Reconstruction of the resultant defect varies widely and depends on the extent of resection of the hypopharyngeal mucosa (see Image 2). Because these tumors often manifest late in their course, total laryngopharyngectomies are common. For small lesions in which only a small amount of mucosa is resected, primary closure may be attempted. If this procedure fails, several options are available, provided a 2-cm wide (or wider) strip of mucosa remains in continuity with the cervical esophagus. The most common closure for this defect is the pectoralis major musculocutaneous rotational flap, with the skin paddle facing into the lumen of the hypopharynx (see Images 3-4).

If a smaller strip of mucosa remains or if the pectoralis flap cannot be used, the next most common reconstruction is the radial forearm fasciocutaneous free flap. Advantages of this procedure include increased tissue pliability (because of decreased muscle bulk) and greater positioning ease (because the flap is not tethered by a muscular pedicle). Unfortunately, this procedure increases the operative time and hospital course. Some studies suggest that the tubed forearm flap yields better swallowing results than the partially tubed pectoralis rotational flap.

Several repair options are available for total laryngopharyngectomy defects. Historically, the Wookey flap was used to restore pharyngeal-esophageal continuity. The procedure consists of internalizing the cervical skin and, through multiple operations, tubing this skin and reconnecting the gullet. Disadvantages include multiple operations and high fistula and stricture rates.

The Wookey flap was replaced by the Bakamjian flap, which uses the rotated deltopectoral fasciocutaneous flap pedicled on the first 3 perforators from the internal mammary system. This method also requires several operations, and, while more reliable than the Wookey flap, it tends to stricture at the distal anastomosis. The tubed pectoralis major flap based on the thoracoacromial artery eventually displaced the Bakamjian flap because this is a one-stage procedure using a very reliable flap with a lower failure rate. The major disadvantage of this flap is the difficulty of completely tubing the skin, subcutaneous fat, and muscle from the chest, especially in women and large individuals.

The advent of free tissue transfer techniques allows a more customized and functional reconstruction in a single stage. The 2 most common are the radial forearm fasciocutaneous flap based on the radial artery and the jejunal free flap based on a mesenteric artery (see Images 5-6). Each has advantages and disadvantages. The jejunum is part of the alimentary tract; thus, it is already lubricated and tubed, eliminating the need for a vertical suture line. However, entering the abdomen to harvest the flap creates an ileus and further slows the recovery process. The forearm flap is more reliable but must undergo metaplasia to a more respiratory-type mucosa, and it needs a vertical suture line to complete the tube. The stricture rate is low for each flap.

For individuals who simply reject the procedure, who are poor candidates for free flaps (because of an inability to tolerate extended general anesthesia or because of vascular problems), or who have tumor extending to the cervical esophagus, the correct reconstructive procedure becomes the gastric pull-up. This entails a mediastinal dissection, complete removal of the esophagus, and passage of the stomach into the neck via the posterior mediastinum (see Image 7). This procedure can be performed from an open abdominal approach or endoscopically (see Image 8). The risks include proximal necrosis of the stomach (with resultant separation), dumping syndrome into the duodenum, and uncontrolled reflux into the neopharynx.

Preoperative Details

Obtain a full oncologic workup to include a complete history, physical examination, head and neck examination, and review of systems. The full workup then includes a CBC count, Chem-7, blood type and screen, chest radiograph, ECG, CT scan, and interventions indicated based on the review of systems. If a radial forearm flap is a reasonable option, perform an Allen test on each arm. A bowel preparation is often used if a jejunal free flap or gastric pull-up is planned. If possible, present the patient's case at a tumor board forum to receive input from all involved physicians. Ensure that voice therapists counsel the patient preoperatively to assist in the transition to alaryngeal speech and to address the difficulties of learning to swallow again. Finally, after the patient has received a full explanation of the procedure, obtain signed consent.

Intraoperative Details

Intubate the supine patient. Prepare the patient with povidone-iodine (Betadine) scrub, and paint to include the lower ears, upper lip, and neck (along the edge of the trapezius). Always prepare the chest in case a pectoralis flap is needed, and include a thigh for a potential split-thickness skin graft. Prepare other areas (eg, forearm, abdomen) if those flaps are planned. Alert the anesthetist that the airway circuit will be changed once the trachea is entered.

Incision

The most common type of access is a U-shaped "apron" flap extending from one mastoid process to the other and crossing the midline approximately 2 cm above the sternal notch. Then, complete the neck dissections in standard fashion. Generally, lateral neck dissections are performed; the submandibular area is not removed, and the sternocleidomastoid muscle, the spinal accessory nerve, and internal jugular vein are all left in the patient. This results in the removal of lymph nodes from levels 2-4.

Tumor removal

Remove attachments of the inferior and middle pharyngeal constrictors to the thyroid cartilage to skeletonize the larynx. Partially free the pyriform mucosa from the thyroid ala. Next, mobilize the hyoid bone by removing all suprahyoid attachments down to the hyoepiglottic ligament. Remove the soft tissues down to the trachea; the thyroid gland can be included or excluded from this dissection. Resect the tumor if it encroaches on a lobe of the thyroid gland. If oncologically possible, preserve at least a portion of thyroid and parathyroid glands. Establish the airway by incision into the larynx, and transfer the anesthesia circuit. Place a Deaver retractor into the mouth, and pass it to the vallecula, which has been inspected previously to ensure an absence of tumor.

If feasible, enter the pharynx on the side opposite the tumor. Cut through the pharyngeal mucosa to expose the tip of the retractor. Under direct visualization, perform pharyngeal cuts around the larynx. This step may include a circumferential or partial pharyngectomy. Remove the larynx by cutting through the back wall of the trachea at the previous incision site. Remove the tumor, achieving a pharyngeal mucosa margin of at least 3 cm.

Reconstruction

If primary closure can be performed, use a running Connell stitch. This stitch is designed to invert the mucosa for a watertight seal. If a strip of mucosa is left in continuity (cranial-caudal), a musculocutaneous pectoralis major flap can be tunneled into the neck, and closure can be performed by suturing the mucosa to the skin paddle. If only a small strip of mucosa remains or if a total pharyngectomy has been performed, a tubed radial forearm free flap can be placed. The authors usually suture the vertical limb while the flap is still pedicled in the forearm. If a total pharyngectomy had been planned, the authors prefer a jejunal flap for reconstruction.

A second team concomitantly harvests the free flap while the resection nears completion. Then, bring the tubed forearm or jejunum flap into the neck and suture the posterior aspect of the superior and inferior anastomosis to the pharyngeal mucosa with interrupted 3-0 polyglycolic sutures. Place the anterior sutures followed by anastomosis of the vascular pedicles. Allow up to a 3- or 4-hour period of ischemia for the jejunal and forearm flaps, respectively. Copiously irrigate the site, and bring down the skin flaps while maturing the tracheostoma with 3-0 monofilament sutures.

Postoperative Details

The first postsurgical night usually entails intensive care unit admission, especially with free-flap reconstructions. The authors monitor the free flap every 4 hours for 3 days with a pinprick using a 25-gauge needle (see Complications). Incline the head of the bed 30�, and obtain vital signs hourly. After the first night, transfer the patient to a step-down unit with nurses specifically trained in the care of patients with airway issues. Continue antibiotic coverage while drains are in place.

Airway

If the underlying pulmonary system allows, extubate at the end of surgery without placing a stent in the tracheostoma. Deliver cool mist via a face tent positioned over the stoma, and add oxygen to keep oxygen saturation above 90%. Commence suctioning every 2-4 hours and as needed.

Nutrition

Begin tube feeding on postoperative day 1 unless the abdomen has been entered for a gastric pull-up or a jejunal free flap, in which case hold feeding until the ileus has resolved. (Food is then delivered via jejunostomy tube.) Stenting of the closure by a feeding tube is unnecessary for either primary approximation of the hypopharynx or flap-assisted closure; thus, the authors use the primary tracheoesophageal puncture site or a gastrostomy tube. The authors rarely use a nasogastric tube. Usually, start oral feeding on postoperative day 6 or 7, provided no serious complication (eg, pharyngocutaneous fistula, flap failure) has occurred. Perform a barium swallow before the initiation of oral alimentation in patients who have received a free flap (see Image 9).

Pain control

Initially, administer morphine via nursing assessment or, if feasible, by patient-controlled analgesia. Switch to oxycodone elixir as soon as enteral feeding has begun; reserve morphine for breakthrough pain.

Drain management

Leave drains until output decreases to 15 mL in 8 hours or until drains have been in for 1 week. The authors are conservative in leaving drains, especially in patients who have received a free flap.

Discharge

Approve patients for discharge when they can perform daily living activities (eg, bathing, toiletry) and can ingest and tolerate sufficient nutrient energy. Generally, this means oral feeding has begun. Occasionally, the feeding tube must be continued, usually due to fistula formation. In addition, uncontrolled infection must be absent. These conditions are usually met at approximately postoperative day 7-10 in patients who have not been irradiated.

Follow-up

Follow-up depends on the type of closure used to repair the neopharynx. Home nursing affords patients an early discharge while maintaining medical oversight. A home nurse also may assist with the management of wounds and tracheostoma. If a free flap has been used, normally schedule the first clinic visit at postoperative day 7-14, depending on postoperative complications.

Once the acute healing process is completed, patients often receive radiation treatments, if not previously administered. Thereafter, follow up every 4-6 weeks the first year, every 8-10 weeks the second year, every 12 weeks the third year, and then annually. Obtain a CT scan at 6 months, sometimes at 1 year, and then only as symptoms indicate. If a tracheoesophageal puncture has been performed, insert the prosthesis after 2 weeks and commence speech therapy.

Complications

Intraoperative

Several complications can occur intraoperatively. They can be divided into technical and nontechnical problems. Nontechnical complications relate to general anesthesia and include malignant hyperthermia, vascular embolus, and diabetes insipidus. Technical complications include excessive hemorrhage, incomplete tumor removal, loss of airway, and excessive operating time.

Postoperative

The most common serious complication is pharyngocutaneous fistula. This usually results from a technical error in suturing the pharynx (with or without a flap), from leaving tumor at the margin, or from radiated tissue with poor blood supply (predisposed to necrose at the distal tip). Fistulas occur in approximately 10-15% of cases. Conservative management yields more satisfactory results than covering the fistula with more tissue. The authors' approach medullizes the fistula from the carotids by opening the tissues further in this direction and then packing the opening with quarter-inch gauze. Over the next few weeks, granulation tissue forms and slowly closes the fistula.

One of the more serious preventable problems is loss of airway. This occurs by mucous plugging, crusting over from the tissue edges, or foreign bodies lodging in the upper airway. Loss of airway can be avoided with attentive nursing care and by strategically placing susceptible patients in rooms near the nursing station.

Carotid blowout is often fatal problem and occurs after the carotid artery is exposed to saliva for some time. Emergent management includes holding pressure over the wound, establishing 2 large-bore intravenous lines, and ordering replacement volume or blood—all while transporting the patient to the operating room. Ligate the carotid as far inferior as possible, then rotate it in a vascularized flap to cover the stump. Attempt to divert the saliva, but the tissues are generally friable and hold sutures poorly. This complication is rare with newer reconstructive techniques.

A chylous fistula can occur but is related to neck dissection. (Essentially, the thin-walled lymph system suffers violation without recognition during surgery.) For output of less than 500 mL/d, place a pressure dressing and change the tube feeding to a medium-weight triglyceride solution. For greater outputs, institute total parenteral nutrition. If drainage fails to slow, then reexplore the wound and oversew the area. Additionally, rotate a muscular pedicled flap from the scalenes to give a second-layer closure to the area.

Flap failure is always possible because of an insufficiency in the arterial or venous pedicle. For free flaps, the problem usually lies in a thrombus formation at the venous anastomosis. Rarely, compression or clotting occurs in the arterial system, leading to insufficient blood flow to the flap. With either case, most major centers achieve a success rate of 93-96%. Maintain vigilant flap inspection during the first 72 hours, when most complications occur. Check flaps every 4 hours during this critical period using the pinprick method (ie, a 25-gauge needle used to express blood from the flap).

Bright red arterial blood indicates a normal system, whereas venous blood indicates early venous pedicle obstruction. No bleeding suggests a backup that halts all ingress of blood. Another method uses Doppler signals (internally or externally) to check flow in the vascular pedicle. Immediately upon discovering the problem, perform emergent exploration and revision of the anastomosis. Approximately 50% of such flaps can be salvaged with an emergent operation.

Various postoperative medical conditions, influenced by patient health state and operation duration, may occur. Fever in the immediate postoperative course is usually due to atelectasis of the lungs, but this may progress to pneumonia. Also, deep venous thromboses may occur, possibly leading to pulmonary emboli. To reduce this possibility, leave compression boots on the patient. Early ambulation helps prevent both problems.

More on Postcricoid Area, Malignant Tumors

Overview: Postcricoid Area, Malignant Tumors
Workup: Postcricoid Area, Malignant Tumors
Treatment: Postcricoid Area, Malignant Tumors
Follow-up: Postcricoid Area, Malignant Tumors
Multimedia: Postcricoid Area, Malignant Tumors
References

References

  1. Akin I, Torkut A, Ustunsoy E, et al. Results of reconstruction with free forearm flap following laryngopharyngo-oesophageal resection. J Laryngol Otol. Jan 1997;111(1):48-53. [Medline].

  2. Arden RL, Rachel JD, Marks SC, Dang K. Volume-length impact of lateral jaw resections on complication rates. Arch Otolaryngol Head Neck Surg. Jan 1999;125(1):68-72. [Medline].

  3. Axon PR, Woolford TJ, Hargreaves SP, et al. A comparison of surgery and radiotherapy in the management of post- cricoid carcinoma. Clin Otolaryngol. Aug 1997;22(4):370-4. [Medline].

  4. Ayshford CA, Walsh RM, Watkinson JC. Reconstructive techniques currently used following resection of hypopharyngeal carcinoma. J Laryngol Otol. Feb 1999;113(2):145-8. [Medline].

  5. Bakamjian VY. Total reconstruction of pharynx with medially based deltopectoral skin flap. N Y State J Med. Nov 1 1968;68(21):2771-8. [Medline].

  6. Bardsley AF, Soutar DS, Elliot D, Batchelor AG. Reducing morbidity in the radial forearm flap donor site. Plast Reconstr Surg. Aug 1990;86(2):287-92; discussion 293-4. [Medline].

  7. Barrett WL, Gluckman JL, Aron BS. Safety of radiating jejunal interposition grafts in head and neck cancer. Am J Clin Oncol. Dec 1997;20(6):609-12. [Medline].

  8. Beauvillain C, Mahe M, Bourdin S, et al. Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas. Laryngoscope. May 1997;107(5):648-53. [Medline].

  9. Blackwell KE, Buchbinder D, Urken ML. Lateral mandibular reconstruction using soft-tissue free flaps and plates. Arch Otolaryngol Head Neck Surg. Jun 1996;122(6):672-8. [Medline].

  10. Bova R, Goh R, Poulson M, Coman WB. Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review. Laryngoscope. May 2005;115(5):864-9. [Medline].

  11. Bowers KW, Edmonds JL, Girod DA, et al. Osteocutaneous radial forearm free flaps. The necessity of internal fixation of the donor-site defect to prevent pathological fracture. J Bone Joint Surg Am. May 2000;82(5):694-704. [Medline].

  12. Boyd JB, Mulholland RS, Davidson J, et al. The free flap and plate in oromandibular reconstruction: long-term review and indications. Plast Reconstr Surg. May 1995;95(6):1018-28. [Medline].

  13. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. Jun 18 1998;338(25):1798-804. [Medline].

  14. Byers RM, Clayman GL, McGill D, et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck. Sep 1999;21(6):499-505. [Medline].

  15. Chisholm M, Ardran GM, Callender ST, Wright R. A follow-up study of patients with post-cricoid webs. Q J Med. Jul 1971;40(159):409-20. [Medline].

  16. Chisholm M. The association between webs, iron and post-cricoid carcinoma. Postgrad Med J. Apr 1974;50(582):215-9. [Medline].

  17. Choi JO, Choi G, Chae SW, Jung KY. Combined use of pectoralis major myocutaneous and free radial forearm flaps for reconstruction of through-and-through defects from excision of head and neck cancers. J Otolaryngol. Dec 1999;28(6):332-6. [Medline].

  18. Chu PY, Chang SY. Reconstruction after resection of hypopharyngeal carcinoma: comparison of the postoperative complications and oncologic results of different methods. Head Neck. Oct 2005;27(10):901-8. [Medline].

  19. Clayman GL, Weber RS, Guillamondegui O, et al. Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers. Arch Otolaryngol Head Neck Surg. Feb 1995;121(2):219-23. [Medline].

  20. Cole I, Hughes L. The relationship of cervical lymph node metastases to primary sites of carcinoma of the upper aerodigestive tract: a pathological study. Aust N Z J Surg. Dec 1997;67(12):860-5. [Medline].

  21. Cordeiro PG, Bacilious N, Schantz S, Spiro R. The radial forearm osteocutaneous "sandwich" free flap for reconstruction of the bilateral subtotal maxillectomy defect. Ann Plast Surg. Apr 1998;40(4):397-402. [Medline].

  22. Cordeiro PG, Santamaria E. A classification system and algorithm for reconstruction of maxillectomy and midfacial defects. Plast Reconstr Surg. Jun 2000;105(7):2331-46; discussion 2347-8. [Medline].

  23. Czaja JM, Gluckman JL. Surgical management of early-stage hypopharyngeal carcinoma. Ann Otol Rhinol Laryngol. Nov 1997;106(11):909-13. [Medline].

  24. Davidson J, Boyd B, Gullane P, et al. A comparison of the results following oromandibular reconstruction using a radial forearm flap with either radial bone or a reconstruction plate. Plast Reconstr Surg. Aug 1991;88(2):201-8. [Medline].

  25. Dikshit RP, Boffetta P, Bouchardy C, et al. Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma. Cancer. Jun 1 2005;103(11):2326-33. [Medline].

  26. El-Deiry M, Funk GF, Nalwa S, et al. Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg. Oct 2005;131(10):879-85.

  27. Ethunandan M, McVicar IH. Preformed above elbow cast for composite radial forearm free flap. Br J Oral Maxillofac Surg. Apr 1996;34(2):193-4. [Medline].

  28. Farrington WT, Weighill JS, Jones PH. Post-cricoid carcinoma (a ten-year retrospective study). J Laryngol Otol. Jan 1986;100(1):79-84. [Medline].

  29. Ferlito A, Rinaldo A. Level I dissection for laryngeal and hypopharyngeal cancer: is it indicated?. J Laryngol Otol. May 1998;112(5):438-40. [Medline].

  30. Foster RD, Anthony JP, Sharma A, Pogrel MA. Vascularized bone flaps versus nonvascularized bone grafts for mandibular reconstruction: an outcome analysis of primary bony union and endosseous implant success. Head Neck. Jan 1999;21(1):66-71. [Medline].

  31. Foster RD, Anthony JP, Singer MI, et al. Microsurgical reconstruction of the midface. Arch Surg. Sep 1996;131(9):960-5; discussion 965-6. [Medline].

  32. Fu KK. Combined-modality therapy for head and neck cancer. Oncology (Huntingt). Dec 1997;11(12):1781-90, 1796; discussion 1796, 179. [Medline].

  33. Fu KK, Cooper JS, Marcial VA, et al. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer. Int J Radiat Oncol Biol Phys. Jun 1 1996;35(3):425-38. [Medline].

  34. Garden AS, Morrison WH, Clayman GL, et al. Early squamous cell carcinoma of the hypopharynx: outcomes of treatment with radiation alone to the primary disease. Head Neck. Jul-Aug 1996;18(4):317-22. [Medline].

  35. Garrett MJ. Megavoltage technique for treatment of carcinoma of the post cricoid region. Clin Radiol. Jan 1971;22(1):136-8. [Medline].

  36. Gavilan J. Controversial issues in the management of the N+ neck. Proceedings from the 5th International Conference on Head and Neck Cancer. San Francisco, Calif; July 29-August 2, 2000:. 443-8.

  37. Giovanoli P, Frey M, Schmid S, Flury R. Free jejunum transfers for functional reconstruction after tumour resections in the oral cavity and the pharynx: changes of morphology and function. Microsurgery. 1996;17(10):535-44. [Medline].

  38. Goldberg P, Leclerc A, Luce D, et al. Laryngeal and hypopharyngeal cancer and occupation: results of a case control-study. Occup Environ Med. Jul 1997;54(7):477-82. [Medline].

  39. Guenel P, Chastang JF, Luce D, et al. A study of the interaction of alcohol drinking and tobacco smoking among French cases of laryngeal cancer. J Epidemiol Community Health. Dec 1988;42(4):350-4. [Medline].

  40. Hartley BE, Bottrill ID, Howard DJ. A third decade''s experience with the gastric pull-up operation for hypopharyngeal carcinoma: changing patterns of use. J Laryngol Otol. Mar 1999;113(3):241-3. [Medline].

  41. Ho CM, Ng WF, Lam KH, et al. Submucosal tumor extension in hypopharyngeal cancer. Arch Otolaryngol Head Neck Surg. Sep 1997;123(9):959-65. [Medline].

  42. Hoffman HT, Karnell LH, Shah JP, et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope. Aug 1997;107(8):1005-17. [Medline].

  43. Inglefield CJ, Kolhe PS. Fracture of the radial forearm osteocutaneous donor site. Ann Plast Surg. Dec 1994;33(6):638-42; discussion 643. [Medline].

  44. International Agency for Research on Cancer Working Group. Alcohol drinking. 13-20 October 1987. IARC Monogr Eval Carcinog Risks Hum. 1988;44:1-378. [Medline].

  45. International Agency for Research on Cancer Working Group. Tobacco smoking. IARC Monogr Eval Carcinog Risk Chem Hum. 1986;38:35-394. [Medline].

  46. Jisander S. Lag screw fixation of composite radial forearm grafts in the reconstruction of mandibular discontinuities. J Oral Maxillofac Surg. Jan 1998;56(1):34-7. [Medline].

  47. Jones NF, Johnson JT, Shestak KC, et al. Microsurgical reconstruction of the head and neck: interdisciplinary collaboration between head and neck surgeons and plastic surgeons in 305 cases. Ann Plast Surg. Jan 1996;36(1):37-43. [Medline].

  48. Julieron M, Germain MA, Schwaab G, et al. Reconstruction with free jejunal autograft after circumferential pharyngolaryngectomy: eighty-three cases. Ann Otol Rhinol Laryngol. Jul 1998;107(7):581-7. [Medline].

  49. Kroll SS, Schusterman MA, Reece GP, et al. Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plast Reconstr Surg. Dec 1996;98(7):1230-3. [Medline].

  50. Kroll SS, Schusterman MA, Reece GP, et al. Choice of flap and incidence of free flap success. Plast Reconstr Surg. Sep 1996;98(3):459-63. [Medline].

  51. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. Jul 3 1996;88(13):890-9. [Medline].

  52. Marmuse JP, Guedon C, Koka VN. Gastric tube transposition for cancer of the hypopharynx and cervical oesophagus. J Laryngol Otol. Jan 1994;108(1):33-7. [Medline].

  53. Mendenhall WM, Amdur RJ, Siemann DW, Parsons JT. Altered fractionation in definitive irradiation of squamous cell carcinoma of the head and neck. Curr Opin Oncol. May 2000;12(3):207-14. [Medline].

  54. Mendenhall WM. Altered fractionation for squamous cell carcinoma of the head and neck. Proceedings from the 5th International Conference on Head and Neck Cancer. San Francisco, Calif; July 29-August 2, 2000:. 63-7.

  55. Montgomery P, Willson PD, Mochloulis G, et al. Laparoscopically assisted total laryngopharyngoesophagectomy with gastric transposition. J Laryngol Otol. Nov 1996;110(11):1072-4. [Medline].

  56. Moore MH, Sinclair SW, Blake GB. The hairless osteotomized radial forearm flap. Plast Reconstr Surg. Aug 1985;76(2):301-6. [Medline].

  57. Nakamura K, Shioyama Y, Sasaki T, et al. Chemoradiation therapy with or without salvage surgery for early squamous cell carcinoma of the hypopharynx. Int J Radiat Oncol Biol Phys. Jul 1 2005;62(3):680-3. [Medline].

  58. Nakatsuka T, Harii K, Asato H, et al. Comparative evaluation in pharyngo-oesophageal reconstruction: radial forearm flap compared with jejunal flap. A 10-year experience. Scand J Plast Reconstr Surg Hand Surg. Sep 1998;32(3):307-10. [Medline].

  59. Nakatsuka T, Harii K, Takushima A, et al. Prefabricated free jejunal transfer: a new reconstructive technique for high pharyngeal defects. Plast Reconstr Surg. Feb 1999;103(2):458-64. [Medline].

  60. Nakatsuka T, Harii K, Yamada A, et al. Dual free flap transfer using forearm flap for mandibular reconstruction. Head Neck. Nov-Dec 1992;14(6):452-8. [Medline].

  61. Nigam A, Campbell JB, Das Gupta AR. Radiation induced tumours of the pharynx--can they be avoided?. J Laryngol Otol. Feb 1990;104(2):129-30. [Medline].

  62. Nunez VA, Pike J, Avery C, et al. Prophylactic plating of the donor site of osteocutaneous radial forearm flaps. Br J Oral Maxillofac Surg. Jun 1999;37(3):210-2. [Medline].

  63. Parsons JT, Mendenhall WM, Stringer SP, et al. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience. Head Neck. Mar-Apr 1993;15(2):87-96. [Medline].

  64. Pearson JG. The radiotherapy of carcinoma of the oesophagus and post cricoid region in south east Scotland. Clin Radiol. Jul 1966;17(3):242-57. [Medline].

  65. Pickford MA, Soutar DS. Intraoral reconstruction using a second free flap for recurrent or metachronous carcinoma. Br J Plast Surg. Dec 1995;48(8):559-63. [Medline].

  66. Pradhan SA. Post-cricoid cancer: an overview. Semin Surg Oncol. 1989;5(5):331-6. [Medline].

  67. Richards SH, Kilby D, Shaw JD. Post-cricoid carcinoma and the Paterson-Kelly syndrome. J Laryngol Otol. Feb 1971;85(2):141-52. [Medline].

  68. Ridge JA. Gene therapy for head and neck cancer. Proceedings from the 5th International Conference on Head and Neck Cancer. San Francisco, Calif; July 29-August 2, 2000:. 83-9.

  69. Rivas B, Carrillo JF, Granados M. Oromandibular reconstruction for oncological purposes. Ann Plast Surg. Jan 2000;44(1):29-35. [Medline].

  70. Robbins KT, Kumar P, Regine WF, et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys. May 1 1997;38(2):263-71. [Medline].

  71. Schusterman MA, Reece GP, Kroll SS, Weldon ME. Use of the AO plate for immediate mandibular reconstruction in cancer patients. Plast Reconstr Surg. Oct 1991;88(4):588-93. [Medline].

  72. Sewnaik A, Hoorweg JJ, Knegt PP, et al. Treatment of hypopharyngeal carcinoma: analysis of nationwide study in the Netherlands over a 10-year period. Clin Otolaryngol. Feb 2005;30(1):52-7. [Medline].

  73. Sidransky D. Molecular diagnosis and gene therapy of head and neck cancer. Proceedings from the 5th International Conference on Head and Neck Cancer. San Francisco, Calif; July 29-August 2, 2000:. 9-13.

  74. Smith AA, Bowen CV, Rabczak T, Boyd JB. Donor site deficit of the osteocutaneous radial forearm flap. Ann Plast Surg. Apr 1994;32(4):372-6. [Medline].

  75. Snow DG, Campbell JB, Smallman LA. Fanconi''s anaemia and post-cricoid carcinoma. J Laryngol Otol. Feb 1991;105(2):125-7. [Medline].

  76. Soutar DS, Widdowson WP. Immediate reconstruction of the mandible using a vascularized segment of radius. Head Neck Surg. Mar-Apr 1986;8(4):232-46. [Medline].

  77. Soutar DS, Scheker LR, Tanner NS, McGregor IA. The radial forearm flap: a versatile method for intra-oral reconstruction. Br J Plast Surg. Jan 1983;36(1):1-8. [Medline].

  78. Spector JG, Sessions DG, Emami B, et al. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results. Laryngoscope. Apr 1995;105(4 Pt 1):397-406. [Medline].

  79. Stell PM, Carden EA, Hibbert J, Dalby JE. Post-cricoid carcinoma. Clin Oncol. Sep 1978;4(3):215-26. [Medline].

  80. Stell PM. Treatment of post-cricoid carcinoma. J R Soc Med. Oct 1979;72(10):716-7. [Medline].

  81. Stell PM, Ramadan MF, George WD. Post-cricoid carcinoma: the place of visceral transposition. Clin Oncol. Mar 1982;8(1):17-20. [Medline].

  82. Stell PM, Ramadan MF, Dalby JE, et al. Management of post-cricoid carcinoma. Clin Otolaryngol. Jun 1982;7(3):145-52. [Medline].

  83. Swanson E, Boyd JB, Manktelow RT. The radial forearm flap: reconstructive applications and donor-site defects in 35 consecutive patients. Plast Reconstr Surg. Feb 1990;85(2):258-66. [Medline].

  84. Swanson E, Boyd JB, Mulholland RS. The radial forearm flap: a biomechanical study of the osteotomized radius. Plast Reconstr Surg. Feb 1990;85(2):267-72. [Medline].

  85. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. Jun 13 1991;324(24):1685-90. [Medline].

  86. Thoma A, Khadaroo R, Grigenas O, et al. Oromandibular reconstruction with the radial-forearm osteocutaneous flap: experience with 60 consecutive cases. Plast Reconstr Surg. Aug 1999;104(2):368-78; discussion 379-80. [Medline].

  87. Thoma A, Allen M, Tadeson BH, et al. The fate of the osteotomized free radial forearm osteocutaneous flap in mandible reconstruction. J Reconstr Microsurg. May 1995;11(3):215-9. [Medline].

  88. Vohra VG, Mukadum FK. Post cricoid cancer. Indian J Cancer. Mar 1973;10(1):45-54. [Medline].

  89. Weinzweig N, Jones NF, Shestak KC, et al. Oromandibular reconstruction using a keel-shaped modification of the radial forearm osteocutaneous flap. Ann Plast Surg. Oct 1994;33(4):359-69; discussion 369-70. [Medline].

  90. Weissler MC, Melin S, Sailer SL, et al. Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. Aug 1992;118(8):806-10. [Medline].

  91. Wenig BM. Atlas of Head and Neck Pathology. Philadelphia, Pa: WB Saunders; 1993.

  92. Wong LY, Wei WI, Lam LK, Yuen AP. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck. Nov 2003;25(11):953-9. [Medline].

  93. Wookey H. The surgical treatment of cancer of the pharynx and upper esophagus. Surg Gynecol Obst. 1942;75:449-506.

  94. Yom SS, Machtay M, Biel MA, et al. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol. Aug 2005;28(4):385-92. [Medline].

  95. Zenn MR, Hidalgo DA, Cordeiro PG, et al. Current role of the radial forearm free flap in mandibular reconstruction. Plast Reconstr Surg. Apr 1997;99(4):1012-7. [Medline].

Further Reading

Keywords

malignant tumors of the postcricoid area, hypopharyngeal carcinoma, hypopharynx cancer, hypopharyngeal cancer, hypopharynx cancer, head and neck cancer, head and neck carcinoma, postcricoid cancer, post-cricoid cancer, postcricoid carcinoma, post-cricoid carcinoma, hypopharyngeal tumor, hypopharynx tumor, hypopharyngeal malignancy, postcricoid malignancy, Plummer-Vinson syndrome, Paterson-Brown-Kelly syndrome, squamous cell carcinoma, SCC, head and neck squamous cell carcinoma, head and neck SCC

Contributor Information and Disclosures

Author

Douglas B Villaret, MD, Residency Director, Assistant Professor, Department of Otolaryngology, Shands Hospital, University of Florida
Douglas B Villaret, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Association for Cancer Research, and American College of Surgeons
Disclosure: Nothing to disclose.

Coauthor(s)

Neal D Futran, MD, Director of Head and Neck Surgery, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Washington School of Medicine
Neal D Futran, MD is a member of the following medical societies: American Head and Neck Society
Disclosure: Nothing to disclose.

Scott P Stringer, MD, MS, FACS, Professor and Chairman, Department of Otolaryngology and Communicative Sciences, University of Mississippi Medical Center; Associate Vice Chancellor for Clinical Affairs
Scott P Stringer, MD, MS, FACS is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American College of Surgeons
Disclosure: Nothing to disclose.

Robert J Amdur, MD, Associate Chairman of Clinical Affairs, Associate Professor, Department of Radiation Oncology, Shands Hospital, University of Florida
Robert J Amdur, MD is a member of the following medical societies: American College of Radiology, American Medical Association, American Society for Therapeutic Radiology and Oncology, and Phi Beta Kappa
Disclosure: Nothing to disclose.

William M Mendenhall, MD, Professor, Department of Radiation Oncology, Shands Hospital, University of Florida
William M Mendenhall, MD is a member of the following medical societies: American College of Radiology, American Radium Society, American Society for Head and Neck Surgery, American Society for Therapeutic Radiology and Oncology, and Florida Medical Association
Disclosure: Nothing to disclose.

Medical Editor

M Abraham Kuriakose, MD, DDS, FRCS, Chairman, Head and Neck Institute, Amrita Institute of Medical Sciences
M Abraham Kuriakose, MD, DDS, FRCS is a member of the following medical societies: American Association for Cancer Research, American Head and Neck Society, British Association of Oral and Maxillofacial Surgeons, and Royal College of Surgeons of England
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Karen Hall Calhoun, MD, Professor, Department of Otolaryngology-Head and Neck Surgery, The Ohio State University
Karen Hall Calhoun, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, American Medical Association, American Rhinologic Society, Association for Research in Otolaryngology, Society of University Otolaryngologists-Head and Neck Surgeons, Southern Medical Association, Texas Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.